首页> 美国卫生研究院文献>European Journal of Hospital Pharmacy >5PSQ-096 Efficacy and security of plasma rich in growth factors eye drops for the treatment of ocular surface diseases
【2h】

5PSQ-096 Efficacy and security of plasma rich in growth factors eye drops for the treatment of ocular surface diseases

机译:5PSQ-096血浆中富含血浆的疗效和安全性因子滴眼液用于治疗眼部疾病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In recent years, there has been increased use of plasma rich in growth factors (PRGF-Endoret) which is extracted from the patient’s blood in order to treat ocular surface diseases. PRGF is a promising tool in ocular surface diseases due to its potential to stimulate and accelerate tissue healing. It contains more platelets and growth factors and it does not include leukocytes.
机译:近年来,在从患者血液中提取的血浆中富含血浆富含血浆(PRGF-octoret)以便治疗眼部疾病。 PRGF由于其刺激和加速组织愈合的可能性,这是一种有前景的眼部疾病的工具。它含有更多的血小板和生长因子,它不包括白细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号